NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Subscribe To Our Newsletter & Stay Updated